Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies

Meyer, 2015, Incidence and prevalence of inflammatory myopathies: a systematic review., Rheumatology (Oxford), 54, 50, 10.1093/rheumatology/keu289

Bohan, 1975, Polymyositis and dermatomyositis (first of two parts)., N Engl J Med, 292, 344, 10.1056/NEJM197502132920706

Bohan, 1975, Polymyositis and dermatomyositis (second of two parts)., N Engl J Med, 292, 403, 10.1056/NEJM197502202920807

van der Meulen, 2003, Polymyositis: an overdiagnosed entity., Neurology, 61, 316, 10.1212/WNL.61.3.316

Amato, 2003, Unicorns, dragons, polymyositis, and other mythological beasts., Neurology, 61, 288, 10.1212/WNL.61.3.288

Griggs, 1995, Inclusion body myositis and myopathies., Ann Neurol, 38, 705, 10.1002/(ISSN)1531-8249

Hoogendijk, 2004, 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, the Netherlands., Neuromuscul Disord, 14, 337, 10.1016/j.nmd.2004.02.006

Matsushita, 2007, Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis., J Rheumatol, 34, 1012

Hamaguchi, 2013, Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome., PLoS One, 8, e60442, 10.1371/journal.pone.0060442

Marguerie, 1990, Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes., Q J Med, 77, 1019, 10.1093/qjmed/77.1.1019

Troyanov, 2005, Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients., Medicine (Baltimore), 84, 231, 10.1097/01.md.0000173991.74008.b0

Love, 1991, A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups., Medicine (Baltimore), 70, 360, 10.1097/00005792-199111000-00002

Mammen, 2011, Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis., Nat Rev Neurol, 7, 343, 10.1038/nrneurol.2011.63

Allenbach, 2013, Usefulness of autoantibodies for the diagnosis of autoimmune myopathies., Rev Neurol (Paris), 169, 656, 10.1016/j.neurol.2013.01.622

Benveniste, 2016, Advances in serological diagnostics of inflammatory myopathies., Curr Opin Neurol, 29, 662, 10.1097/WCO.0000000000000376

Benveniste, 2011, Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy., Arthritis Rheum, 63, 1961, 10.1002/art.v63.7

Drouot, 2014, Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies., Arthritis Res Ther, 16, R39, 10.1186/ar4468

Askanas, 2007, Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis., Curr Opin Rheumatol, 19, 550, 10.1097/BOR.0b013e3282efdc7c

Askanas, 2015, Sporadic inclusion-body myositis: a degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy., Biochim Biophys Acta, 1852, 633, 10.1016/j.bbadis.2014.09.005

Bronner, 2004, Polymyositis: an ongoing discussion about a disease entity., Arch Neurol, 61, 132, 10.1001/archneur.61.1.132

Benveniste, 2011, Long-term observational study of sporadic inclusion body myositis., Brain, 134, 3176, 10.1093/brain/awr213

Allenbach, 2012, Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis., Neuromuscul Disord, 22, 980, 10.1016/j.nmd.2012.05.004

Lloyd, 2014, Evaluation and construction of diagnostic criteria for inclusion body myositis., Neurology, 83, 426, 10.1212/WNL.0000000000000642

Pinal-Fernandez, 2017, Longitudinal course of disease in a large cohort of myositis patients With autoantibodies recognizing the signal recognition particle., Arthritis Care Res (Hoboken), 69, 263, 10.1002/acr.v69.2

Mammen, 2011, Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy., Arthritis Rheum, 63, 713, 10.1002/art.30156

Lundberg, 2017, 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups., Arthritis Rheumatol, 69, 2271, 10.1002/art.40320

Allenbach, 2018, 224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016., Neuromuscul Disord, 28, 87, 10.1016/j.nmd.2017.09.016

Bottai, 2017, EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report., RMD Open, 3, e000507, 10.1136/rmdopen-2017-000507

Suzuki, 2017, Integrated Diagnosis Project for Inflammatory Myopathies: An association between autoantibodies and muscle pathology, Autoimmun Rev, 16, 693, 10.1016/j.autrev.2017.05.003